U.S. markets open in 3 hours 3 minutes
  • S&P Futures

    3,858.25
    +39.00 (+1.02%)
     
  • Dow Futures

    31,953.00
    +177.00 (+0.56%)
     
  • Nasdaq Futures

    12,561.00
    +263.75 (+2.14%)
     
  • Russell 2000 Futures

    2,234.30
    +33.50 (+1.52%)
     
  • Crude Oil

    65.72
    +0.67 (+1.03%)
     
  • Gold

    1,702.50
    +24.50 (+1.46%)
     
  • Silver

    25.80
    +0.53 (+2.10%)
     
  • EUR/USD

    1.1916
    +0.0064 (+0.54%)
     
  • 10-Yr Bond

    1.5960
    0.0000 (0.00%)
     
  • Vix

    24.43
    -0.23 (-0.93%)
     
  • GBP/USD

    1.3888
    +0.0066 (+0.48%)
     
  • USD/JPY

    108.6600
    -0.2410 (-0.22%)
     
  • BTC-USD

    54,072.13
    +4,069.60 (+8.14%)
     
  • CMC Crypto 200

    1,091.82
    +67.62 (+6.60%)
     
  • FTSE 100

    6,770.88
    +51.75 (+0.77%)
     
  • Nikkei 225

    29,027.94
    +284.69 (+0.99%)
     

Homology Medicines (FIXX) Looks Good: Stock Adds 8% in Session

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Zacks Equity Research
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Homology Medicines, Inc. FIXX was a big mover last session, as the company saw its shares rise more than 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $14.61 to $16.58 in the past one-month time frame.

The company's Zacks Consensus Estimate for the current quarter has moved higher over the past few weeks, suggesting that more solid trading could be ahead for Homology Medicines. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Homology Medicines currently has a Zacks Rank #4 (Sell) while its Earnings ESP is positive.

Investors interested in the Medical - Generic Drugs industry may consider Voyager Therapeutics, Inc. VYGR, which has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

5 Stocks to Soar Past the Pandemic: In addition to the companies you learned about above, we invite you to learn about 5 cutting-edge stocks that could skyrocket from the exponential increase in demand for “stay at home” technologies. This could be one of the biggest buying opportunities of the decade.

See the 5 high-tech stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Voyager Therapeutics, Inc. (VYGR) : Free Stock Analysis Report
 
Homology Medicines, Inc. (FIXX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research